Ascierto, P. A., Ribas, A., Larkin, J., McArthur, G. A., Lewis, K. D., Hauschild, A., . . . Dréno, B. (2020). Impact of initial treatment and prognostic factors on postprogression survival in BRAF-mutated metastatic melanoma treated with dacarbazine or vemurafenib ± cobimetinib: A pooled analysis of four clinical trials. J Transl Med.
Chicago Stili AlıntıAscierto, Paolo A., et al. "Impact of Initial Treatment and Prognostic Factors On Postprogression Survival in BRAF-mutated Metastatic Melanoma Treated With Dacarbazine or Vemurafenib ± cobimetinib: A Pooled Analysis of Four Clinical Trials." J Transl Med 2020.
MLA AlıntıAscierto, Paolo A., et al. "Impact of Initial Treatment and Prognostic Factors On Postprogression Survival in BRAF-mutated Metastatic Melanoma Treated With Dacarbazine or Vemurafenib ± cobimetinib: A Pooled Analysis of Four Clinical Trials." J Transl Med 2020.